Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse

Dec 26, 2008 - Allergan, Inc. today announced the U.S. Food and Drug Administration has approved LATISSE (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes.

The details can be read here.